Labdentica - Company finances
|
EUR
|
2022
From: 2022-01-19
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 17,399 | 17,860 | 27,236 | 20,098 |
| Profit before tax | 10,880 | 5,794 | - | 13,796 |
| Net profit | 10,880 | 5,504 | 10,773 | 13,796 |
| Equity | 10,980 | 16,483 | 17,856 | 7,241 |
| Liabilities | 604 | 326 | 1,184 | 928 |
| Non-current assets | 3,296 | 2,540 | 5,716 | 3,892 |
| Current assets | 8,288 | 14,269 | 13,324 | 4,277 |
| Total assets | 11,584 | 16,809 | 19,040 | 8,169 |
|
Taxes paid
|
||||
| STI taxes | - | - | 1,200 | 3,176 |
|
Financial indicators
|
||||
| Revenue change y/y | - | +2.6% | +52.5% | -26.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 93.9% | 32.7% | 56.6% | 168.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 99.1% | 33.4% | 60.3% | 190.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 62.5% | 30.8% | 39.6% | 68.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 62.5% | 32.4% | - | 68.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.0 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Labdentica - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-06-04 | 2024-06-30 | 50.95 |
| 2023-07-19 | 2023-07-31 | 50.00 |
Labdentica - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-31 | 2026-02-27 | 9.93 |
| 2026-01-20 | 2026-01-30 | 50.84 |
| 2026-01-19 | 2026-01-19 | 3200.84 |
| 2026-01-18 | 2026-01-18 | 3199.2 |
| 2026-01-17 | 2026-01-17 | 3186.08 |
| 2026-01-10 | 2026-01-16 | 3150.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Labdentica, MB (code 305983632) is a Lithuanian small partnership engaged in the manufacture of other medical and dental devices, instruments and supplies. In 2025, the company generated revenue of EUR 20.1K, down 26.2% year on year after reaching EUR 27.2K in 2024, but still above the EUR 17.9K reported in 2023. Net profit improved to EUR 13.8K in 2025 from EUR 10.8K in 2024 and EUR 5.5K in 2023, while the profit margin widened to 68.6%. This indicates that although turnover softened in the latest year, profitability remained strong. The balance sheet contracted in 2025, with total assets falling to EUR 8.2K from EUR 19.0K in 2024, equity decreasing to EUR 7.2K, and liabilities limited to EUR 928. The company still maintained a high equity ratio of 88.6% and a low debt-to-equity ratio of 0.13. Asset turnover reached 2.46x in 2025, showing efficient use of a smaller asset base. Profitability relative to equity and assets remained very strong in the latest year.